Противопаразитарные Препараты

Astellas Pharma

Astellas Pharma to acquire Propella Therapeutic...

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas Pharma EMEA celebrates its 10th annive...

Astellas

Astellas Home page | Astellas Pharma Inc.

FDA Approves Astellas’ Non-hormonal Menopause T...

Pharmaceutical Technology

Astellas Pharma - Global Web Site on Behance

Атлас лекарственных растений - YouTube

About | Astellas Pharma Ltd

Главная | Astellas Pharma Russia

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas introduces sustainable community initi...

Astellas Offloads 5 Legacy Products to Germany’...

Главная | Astellas Pharma Russia

Astellas' Prostate Cancer Drug Available In Jap...

FDA Grants Full Approval for Astellas Pharma's ...

Astellas Home page | Astellas Pharma Inc.

Astellas Sues Over New Myrbetriq Patent to Reca...

China Formally Arrests Japanese Employee of Dru...

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Home | Astellas Pharma Canada, Inc.

US FDA approves Astellas Pharma pill for menopa...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas Pharmaceuticals Establishes Open Innov...

Astellas Pharma Joins Record Bond Sales by Japa...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas, University of Tokyo extend partnershi...

Astellas gets FDA priority review for gastric c...

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Japan's Astellas sees cancer drug fueling 29% p...